Jingfeng Pharmaceutical(SZ:000908) Zheng Quan Shi Bao Wang·2025-10-22 00:59Group 1 - ST Jingfeng (000908) will be subject to delisting risk warning starting October 23, 2025, due to the acceptance of a reorganization application by the Changde Intermediate People's Court [1] - The stock will be renamed to "*ST Jingfeng" with a daily price fluctuation limit of 5%, and it will be suspended for one day on October 22, 2025 [1] - As of the end of 2023, ST Jingfeng reported negative net assets and faced liquidity issues, leading to overdue bonds and previous delisting risk warnings [1] Group 2 - Yushu Technology has completed the first phase of its IPO guidance work, with the report published on the CSRC website detailing the progress [3][5] - The guidance period started on July 18, 2025, and aims to improve corporate governance and operational standards [5] - Yushu Technology plans to submit its IPO application documents between October and December 2025, with relevant operational data to be disclosed at that time [6] Group 3 - The Yushu Robotics concept stocks have shown strong performance this year, with an average price increase of 71.37%, significantly outperforming the Shanghai Composite Index [7] - Notable stocks include Zhejiang Rongtai, Wolong Electric Drive, and Zhongdali De, with year-to-date price increases of 316.38%, 240.73%, and 202.54% respectively [8] - Companies like Aobi Zhongguang-UW have reported positive earnings forecasts, benefiting from advancements in the 3D vision perception industry and expanding application scenarios [9]